When it comes to clinical trials for a new medications, children are hardly ever included. As a result, most prescriptions for children are often more uncertain than for adults. According to Scientific American, only 46 percent of drugs used in kids have been approved by the U.S. Food and Drug Administration (FDA) for pediatric populations.
In the past, that statistic was much worse. Two pieces of litigation have been crucial to improving the rate of FDA approved drugs for kids. One law is The Best Pharmaceuticals for Children Act, which provides motivation by offering exclusive sale rights for a short period of time. The other law is the Pediatric Research Equity Act, which requires clinical testing in children if a drug can be used for the same purpose in children. The issue with this however, is that children often get diseases that adults do not. More Limited Data on Medication Dosage for Children Leads to Uncertain Prescriptions